Medidata Solutions Inc (MDSO) Holdings Trimmed by BlackRock Inc.

BlackRock Inc. lowered its stake in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 5.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,799,838 shares of the company’s stock after selling 372,355 shares during the period. BlackRock Inc. owned approximately 11.11% of Medidata Solutions worth $498,496,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Oregon Public Employees Retirement Fund raised its stake in Medidata Solutions by 3.0% during the second quarter. Oregon Public Employees Retirement Fund now owns 22,786 shares of the company’s stock worth $1,836,000 after purchasing an additional 666 shares during the period. Polen Capital Management LLC raised its stake in Medidata Solutions by 12.2% during the second quarter. Polen Capital Management LLC now owns 7,413 shares of the company’s stock worth $597,000 after purchasing an additional 806 shares during the period. Metropolitan Life Insurance Co. NY raised its stake in Medidata Solutions by 3.0% during the second quarter. Metropolitan Life Insurance Co. NY now owns 34,464 shares of the company’s stock worth $2,776,000 after purchasing an additional 993 shares during the period. Arizona State Retirement System raised its stake in Medidata Solutions by 2.6% during the second quarter. Arizona State Retirement System now owns 41,117 shares of the company’s stock worth $3,312,000 after purchasing an additional 1,038 shares during the period. Finally, Swiss National Bank raised its stake in Medidata Solutions by 1.4% during the third quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $7,573,000 after purchasing an additional 1,400 shares during the period.

A number of equities analysts have weighed in on MDSO shares. Piper Jaffray Companies cut their price target on shares of Medidata Solutions from $96.00 to $93.00 in a research note on Thursday, October 18th. ValuEngine downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Monday, September 17th. BidaskClub raised shares of Medidata Solutions from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 16th. Zacks Investment Research downgraded shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, October 16th. Finally, JPMorgan Chase & Co. cut their target price on shares of Medidata Solutions to $74.00 and set a “neutral” rating on the stock in a research note on Friday, October 19th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $85.10.

In related news, CFO Rouven Bergmann sold 10,000 shares of the firm’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $79.00, for a total transaction of $790,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael I. Otner sold 7,030 shares of the firm’s stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $69.40, for a total transaction of $487,882.00. Following the sale, the executive vice president now directly owns 62,548 shares of the company’s stock, valued at $4,340,831.20. The disclosure for this sale can be found here. In the last three months, insiders sold 34,030 shares of company stock worth $2,539,022. Insiders own 4.70% of the company’s stock.

Shares of MDSO stock opened at $72.67 on Friday. Medidata Solutions Inc has a 52 week low of $59.60 and a 52 week high of $88.87. The company has a current ratio of 2.52, a quick ratio of 2.52 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $4.62 billion, a PE ratio of 85.49, a price-to-earnings-growth ratio of 4.47 and a beta of 1.30.

Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Thursday, October 18th. The company reported $0.42 EPS for the quarter, beating the Zacks’ consensus estimate of $0.36 by $0.06. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The business had revenue of $163.41 million for the quarter, compared to the consensus estimate of $162.09 million. During the same quarter last year, the firm posted $0.33 EPS. The business’s revenue for the quarter was up 17.6% compared to the same quarter last year. On average, equities analysts expect that Medidata Solutions Inc will post 0.85 earnings per share for the current year.

WARNING: “Medidata Solutions Inc (MDSO) Holdings Trimmed by BlackRock Inc.” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/12/08/medidata-solutions-inc-mdso-holdings-trimmed-by-blackrock-inc.html.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Recommended Story: How can investors find ex-dividend dates?

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply